Evidence map›Paper›PMID 26153450›Full record

Trial reportAnnals of neurology2015

Time to endovascular reperfusion and degree of disability in acute stroke.

Sunil A Sheth, Reza Jahan, Jan Gralla, Vitor M Pereira, Raul G Nogueira, Elad I Levy, Osama O Zaidat, Jeffrey L Saver, SWIFT-STAR Trialists

Open access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Annals of neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 5 pooled it
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 5 syntheses or guidelines pooled it, 185 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Large vessel occlusion detection by non-contrast CT using artificial ıntelligence.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Sunil A ShethDivision of Interventional Neuroradiology and Stroke Center, University of California, Los Angeles, CA.
Reza JahanDivision of Interventional Neuroradiology and Stroke Center, University of California, Los Angeles, CA.
Jan GrallaDepartment of Diagnostic and Interventional Neuroradiology, Inselspital, University of Bern, Bern, Switzerland.
Vitor M PereiraDepartments of Medical Imaging and Surgery, Toronto Western Hospital and University Health Network, University of Toronto, Toronto, Ontario, Canada.
Raul G NogueiraDepartment of Neurology, Emory University, Atlanta, GA.
Elad I LevyDepartments of Neurosurgery and Radiology and Toshiba Stroke and Vascular Research Center, University at Buffalo, State University of New York.
Osama O ZaidatDepartment of Neurology, Medical College of Wisconsin, Milwaukee, WI.
Jeffrey L SaverDepartment of Neurology and Stroke Center, University of California, Los Angeles, CA.
SWIFT-STAR Trialists
University of California, Los Angeles · USEmory University · USMedical College of Wisconsin · USToshiba (United States) · USUniversity Hospital of Bern · CHUniversity of Toronto · CA

Funding

UCLA SPOTRIAS CENTER APPLICATION RENEWAL-PROGRAM PROJECTP50NS044378 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SAVER, JEFFREY L · 2003 to 2012
$17.2M
Los Angeles - Southern California NINDS Stroke Trial Network (LASC NSTN)U10NS086497 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SAVER, JEFFREY L, SUNG, GENE YONG · 2013 to 2017
$2.0M
NINDS NIH HHS P50 NS044378NINDS NIH HHS U10 NS086497
6 · The paper itself

Abstract

objectiveFaster time from onset to recanalization (OTR) in acute ischemic stroke using endovascular therapy (ET) has been associated with better outcome. However, previous studies were based on less-effective first-generation devices, and analyzed only dichotomized disability outcomes, which may underestimate the full effect of treatment.

methodsIn the combined databases of the SWIFT and STAR trials, we identified patients treated with the Solitaire stent retriever with achievement of substantial reperfusion (Thrombolysis in Cerebral Infarction [TICI] 2b-3). Ordinal numbers needed to treat values were derived by populating joint outcome tables.

resultsAmong 202 patients treated with ET with TICI 2b to 3 reperfusion, mean age was 68 (±13), 62% were female, and median National Institutes of Health Stroke Scale (NIHSS) score was 17 (interquartile range [IQR]: 14-20). Day 90 modified Rankin Scale (mRS) outcomes for OTR time intervals ranging from 180 to 480 minutes showed substantial time-related reductions in disability across the entire outcome range. Shorter OTR was associated with improved mean 90-day mRS (1.4 vs. 2.4 vs. 3.3, for OTR groups of 124-240 vs. 241-360 vs. 361-660 minutes; p < 0.001). The number of patients identified as benefitting from therapy with shorter OTR were 3-fold (range, 1.5-4.7) higher on ordinal, compared with dichotomized analysis. For every 15-minute acceleration of OTR, 34 per 1,000 treated patients had improved disability outcome.

interpretationAnalysis of disability over the entire outcome range demonstrates a marked effect of shorter time to reperfusion upon improved clinical outcome, substantially higher than binary metrics. For every 5-minute delay in endovascular reperfusion, 1 of 100 patients has a worse disability outcome.

Indexed as

InternationalityPersons with DisabilitiesAgedAged, 80 and overEndovascular ProceduresFemaleHumansMaleMiddle AgedProspective StudiesReperfusionSingle-Blind MethodStrokeTime Factors

Identifiers

PMID26153450
PMCPMC4955570
OpenAlexW1743074346

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.